These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 38812815

  • 1. Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.
    Yavas Abalı Z, Guran T.
    Front Endocrinol (Lausanne); 2024; 15():1354759. PubMed ID: 38812815
    [Abstract] [Full Text] [Related]

  • 2. Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective.
    Nagaraja MR, Gubbala SP, Delphine Silvia CRW, Amanchy R.
    Syst Biol Reprod Med; 2019 Apr; 65(2):105-120. PubMed ID: 30550360
    [Abstract] [Full Text] [Related]

  • 3.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Délot EC, Vilain EJ.
    ; 1993 Apr. PubMed ID: 20301589
    [Abstract] [Full Text] [Related]

  • 4. 46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.
    Baronio F, Ortolano R, Menabò S, Cassio A, Baldazzi L, Di Natale V, Tonti G, Vestrucci B, Balsamo A.
    Int J Mol Sci; 2019 Sep 17; 20(18):. PubMed ID: 31533357
    [Abstract] [Full Text] [Related]

  • 5. Clinical review of 95 patients with 46,XX disorders of sex development based on the new Chicago classification.
    Öcal G, Berberoğlu M, Sıklar Z, Aycan Z, Hacıhamdioglu B, Savas Erdeve Ş, Çamtosun E, Kocaay P, Ruhi HI, Kılıç BG, Tukun A.
    J Pediatr Adolesc Gynecol; 2015 Feb 17; 28(1):6-11. PubMed ID: 25444050
    [Abstract] [Full Text] [Related]

  • 6. Are NR5A1 Variations a Frequent Cause of 46,XX Ovotesticular Disorders of Sex Development? Analysis from a Single Center and Systematic Review.
    Barros BA, Guaragna MS, Fabbri-Scallet H, Palandi de Mello M, Guerra-Júnior G, Maciel-Guerra AT.
    Sex Dev; 2022 Feb 17; 16(4):242-251. PubMed ID: 36657429
    [Abstract] [Full Text] [Related]

  • 7. Testicular differentiation in 46,XX DSD: an overview of genetic causes.
    Ferrari MTM, Silva ESDN, Nishi MY, Batista RL, Mendonca BB, Domenice S.
    Front Endocrinol (Lausanne); 2024 Feb 17; 15():1385901. PubMed ID: 38721146
    [Abstract] [Full Text] [Related]

  • 8. Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects.
    Grinspon RP, Rey RA.
    Sex Dev; 2016 Feb 17; 10(1):1-11. PubMed ID: 27055195
    [Abstract] [Full Text] [Related]

  • 9. 46,XX Differences of Sex Development outside congenital adrenal hyperplasia: pathogenesis, clinical aspects, puberty, sex hormone replacement therapy and fertility outcomes.
    Stancampiano MR, Meroni SLC, Bucolo C, Russo G.
    Front Endocrinol (Lausanne); 2024 Feb 17; 15():1402579. PubMed ID: 38841305
    [Abstract] [Full Text] [Related]

  • 10. Disorders of Sex Development of Adrenal Origin.
    Finkielstain GP, Vieites A, Bergadá I, Rey RA.
    Front Endocrinol (Lausanne); 2021 Feb 17; 12():770782. PubMed ID: 34987475
    [Abstract] [Full Text] [Related]

  • 11. Nuclear Receptor Gene Variants Underlying Disorders/Differences of Sex Development through Abnormal Testicular Development.
    Hattori A, Fukami M.
    Biomolecules; 2023 Apr 19; 13(4):. PubMed ID: 37189438
    [Abstract] [Full Text] [Related]

  • 12. A Duplication Upstream of SOX9 Associated with SRY Negative 46,XX Ovotesticular Disorder of Sex Development: A Case Report.
    Mengen E, Kayhan G, Kocaay P, Uçaktürk SA.
    J Clin Res Pediatr Endocrinol; 2020 Sep 02; 12(3):308-314. PubMed ID: 31476840
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes in non-CAH 46,XX DSD.
    Grouthier V, Bachelot A.
    Front Endocrinol (Lausanne); 2024 Sep 02; 15():1372887. PubMed ID: 38752171
    [Abstract] [Full Text] [Related]

  • 14. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals.
    Kousta E, Papathanasiou A, Skordis N.
    Hormones (Athens); 2010 Sep 02; 9(3):218-131. PubMed ID: 20688619
    [Abstract] [Full Text] [Related]

  • 15. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country.
    Utari A, Faradz SMH, Ediati A, Rinne T, Ariani MD, Juniarto AZ, Drop SLS, van Herwaarden AE, Claahsen-van der Grinten HL.
    Front Endocrinol (Lausanne); 2022 Sep 02; 13():1015973. PubMed ID: 36589846
    [Abstract] [Full Text] [Related]

  • 16. Initial assessment of a child with suspected disorder of sex development.
    Ahmad A, Ayub F, Saleem I, Ahmad N.
    J Pak Med Assoc; 2019 May 02; 69(5):711-717. PubMed ID: 31105293
    [Abstract] [Full Text] [Related]

  • 17. Identical NR5A1 Missense Mutations in Two Unrelated 46,XX Individuals with Testicular Tissues.
    Igarashi M, Takasawa K, Hakoda A, Kanno J, Takada S, Miyado M, Baba T, Morohashi KI, Tajima T, Hata K, Nakabayashi K, Matsubara Y, Sekido R, Ogata T, Kashimada K, Fukami M.
    Hum Mutat; 2017 Jan 02; 38(1):39-42. PubMed ID: 27610946
    [Abstract] [Full Text] [Related]

  • 18. Methylation Patterns of SOX3, SOX9, and WNT4 Genes in Gonads of Dogs with XX (SRY-Negative) Disorder of Sexual Development.
    Salamon S, Flisikowski K, Switonski M.
    Sex Dev; 2017 Jan 02; 11(2):86-93. PubMed ID: 28365713
    [Abstract] [Full Text] [Related]

  • 19. Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings.
    Globa E, Zelinska N, Shcherbak Y, Bignon-Topalovic J, Bashamboo A, MсElreavey K.
    Front Endocrinol (Lausanne); 2022 Jan 02; 13():810782. PubMed ID: 35432193
    [Abstract] [Full Text] [Related]

  • 20. A Novel Homozygous CYP19A1 Gene Mutation: Aromatase Deficiency Mimicking Congenital Adrenal Hyperplasia in an Infant without Obvious Maternal Virilisation.
    Dursun F, Ceylaner S.
    J Clin Res Pediatr Endocrinol; 2019 May 28; 11(2):196-201. PubMed ID: 30074481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.